JP2024512765A5 - - Google Patents
Info
- Publication number
- JP2024512765A5 JP2024512765A5 JP2023560819A JP2023560819A JP2024512765A5 JP 2024512765 A5 JP2024512765 A5 JP 2024512765A5 JP 2023560819 A JP2023560819 A JP 2023560819A JP 2023560819 A JP2023560819 A JP 2023560819A JP 2024512765 A5 JP2024512765 A5 JP 2024512765A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- administered
- cpis
- therapeutically effective
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163169674P | 2021-04-01 | 2021-04-01 | |
| US63/169,674 | 2021-04-01 | ||
| US202263298589P | 2022-01-11 | 2022-01-11 | |
| US63/298,589 | 2022-01-11 | ||
| PCT/US2022/022801 WO2022212690A1 (en) | 2021-04-01 | 2022-03-31 | Cancer therapy using toll-like receptor agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024512765A JP2024512765A (ja) | 2024-03-19 |
| JP2024512765A5 true JP2024512765A5 (https=) | 2025-04-08 |
Family
ID=83456830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560819A Pending JP2024512765A (ja) | 2021-04-01 | 2022-03-31 | トール様受容体アゴニストを使用したがん治療 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4313315A4 (https=) |
| JP (1) | JP2024512765A (https=) |
| KR (1) | KR20240004419A (https=) |
| AU (1) | AU2022249092A1 (https=) |
| CA (1) | CA3215582A1 (https=) |
| DE (1) | DE112022001882T9 (https=) |
| WO (1) | WO2022212690A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024243794A1 (en) * | 2023-04-06 | 2025-11-06 | Trisalus Life Sciences, Inc. | System and device for providing localized turbulence for delivering a medical embolizing agent |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100881923B1 (ko) | 2000-12-27 | 2009-02-04 | 다이나박스 테크놀로지 코퍼레이션 | 면역자극 폴리뉴클레오티드 및 그것의 사용 방법 |
| US20040009151A1 (en) * | 2002-04-04 | 2004-01-15 | Kay Mark A. | Methods for delivering recombinant adeno-associated virus virions to the liver of a mammal |
| US8158768B2 (en) | 2002-12-23 | 2012-04-17 | Dynavax Technologies Corporation | Immunostimulatory sequence oligonucleotides and methods of using the same |
| US7963956B2 (en) * | 2003-04-22 | 2011-06-21 | Antisense Pharma Gmbh | Portable equipment for administration of fluids into tissues and tumors by convection enhanced delivery technique |
| US8696698B2 (en) | 2009-12-02 | 2014-04-15 | Surefire Medical, Inc. | Microvalve protection device and method of use for protection against embolization agent reflux |
| US8500775B2 (en) | 2009-12-02 | 2013-08-06 | Surefire Medical, Inc. | Protection device and method against embolization agent reflux |
| US9539081B2 (en) | 2009-12-02 | 2017-01-10 | Surefire Medical, Inc. | Method of operating a microvalve protection device |
| US9770319B2 (en) | 2010-12-01 | 2017-09-26 | Surefire Medical, Inc. | Closed tip dynamic microvalve protection device |
| US9968740B2 (en) | 2014-03-25 | 2018-05-15 | Surefire Medical, Inc. | Closed tip dynamic microvalve protection device |
| PL3240801T3 (pl) * | 2014-12-31 | 2021-06-14 | Checkmate Pharmaceuticals, Inc. | Skojarzona immunoterapia nowotworów |
| US20160287839A1 (en) | 2015-03-31 | 2016-10-06 | Surefire Medical, Inc. | Apparatus and Method for Infusing an Immunotherapy Agent to a Solid Tumor for Treatment |
| KR20180014009A (ko) * | 2015-05-29 | 2018-02-07 | 머크 샤프 앤드 돔 코포레이션 | 암을 치료하기 위한 pd-1 길항제 및 cpg-c 유형 올리고뉴클레오티드의 조합 |
| SG11201808913WA (en) * | 2016-04-15 | 2018-11-29 | Dynavax Tech Corp | Intratumoral administration of particles containing a toll-like receptor 9 agonist and a tumor antigen for treating cancer |
| US10806893B2 (en) | 2017-01-10 | 2020-10-20 | Surefire Medical, Inc. | Guiding catheter having shape-retentive distal end |
| US10588636B2 (en) | 2017-03-20 | 2020-03-17 | Surefire Medical, Inc. | Dynamic reconfigurable microvalve protection device |
| US20190298983A1 (en) | 2018-01-15 | 2019-10-03 | Surefire Medical, Inc. | Injection Port for Therapeutic Delivery |
| WO2019160866A2 (en) * | 2018-02-13 | 2019-08-22 | Checkmate Pharmaceuticals, Inc. | Compositions and methods for tumor immunotherapy |
| US11850398B2 (en) | 2018-08-01 | 2023-12-26 | Trisalus Life Sciences, Inc. | Systems and methods for pressure-facilitated therapeutic agent delivery |
| US12433597B2 (en) | 2019-06-04 | 2025-10-07 | Trisalus Life Sciences, Inc. | Atraumatic occlusive system with compartment for measurement of vascular pressure change |
| WO2021011496A1 (en) * | 2019-07-12 | 2021-01-21 | Oregon Health & Science University | Immunotherapeutic constructs and methods of their use |
| IL294621A (en) * | 2020-01-10 | 2022-09-01 | Sbi Biotech Co Ltd | Tlr9 agonist oligonucleotides, compositions comprising same and uses thereof |
| CA3196273A1 (en) * | 2020-09-22 | 2022-03-31 | Trisalus Life Sciences, Inc. | Cancer therapy using toll-like receptor agonists |
-
2022
- 2022-03-31 JP JP2023560819A patent/JP2024512765A/ja active Pending
- 2022-03-31 KR KR1020237037584A patent/KR20240004419A/ko active Pending
- 2022-03-31 EP EP22782201.2A patent/EP4313315A4/en active Pending
- 2022-03-31 CA CA3215582A patent/CA3215582A1/en active Pending
- 2022-03-31 WO PCT/US2022/022801 patent/WO2022212690A1/en not_active Ceased
- 2022-03-31 AU AU2022249092A patent/AU2022249092A1/en active Pending
- 2022-03-31 DE DE112022001882.8T patent/DE112022001882T9/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mercadante | The use of anti-inflammatory drugs in cancer pain | |
| JP2022531939A5 (https=) | ||
| JP2023166388A5 (https=) | ||
| JP2002532392A5 (https=) | ||
| JP2024518947A5 (https=) | ||
| JP2011251975A5 (https=) | ||
| Kang et al. | In vivo evaluation of oral anti-tumoral effect of 3, 4-dihydroquinazoline derivative on solid tumor | |
| JP2017510579A5 (https=) | ||
| NZ598534A (en) | Dosage regimen of an s1p receptor modulator | |
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| JP2023552700A5 (https=) | ||
| EP2034980A1 (en) | Methods and compositions for the treatment of viral infections | |
| MX2023003041A (es) | Métodos para administrar dosis terapéuticas de moléculas de acoplamiento a células t biespecíficas para el tratamiento de cáncer. | |
| JP2019504012A5 (https=) | ||
| JP2023514992A5 (https=) | ||
| JP2024512765A5 (https=) | ||
| AU2013208649A1 (en) | Combination therapy for the treatment of cancer | |
| TWI483721B (zh) | The use of a composition containing a ferrous amino acid chelate for the manufacture of anti-cancer medicaments | |
| JP2024016209A5 (https=) | ||
| JP2008540364A5 (https=) | ||
| JP2025148449A5 (https=) | ||
| JP2024517085A5 (https=) | ||
| JP2021004249A5 (https=) | ||
| Park et al. | Ticagrelor-induced acute kidney injury can increase serum concentration of statin and lead to concurrence of rhabdomyolysis | |
| JP2023501781A5 (https=) |